a16z Podcast | What's in the Water at the George Church Lab?

CRISPR Baby Analysis

• George Church identifies the Chinese CRISPR baby case (CCR5 knockout for HIV resistance) as the most likely "first" outcome of germline editing over mammoth or Neanderthal projects due to a clearer technical path and divergent ethical opinions.
• The project was not a rogue solo effort; Church notes the author list was long and implies the Chinese government, monitoring topics like biological encryption and nuclear issues, was likely aware.
• The experiment involved knocking out the CCR5 gene to prevent HIV infection, a strategy analogous to a vaccine rather than a cure, utilizing a known biological precedent where ~10% of Europeans naturally possess double-null CCR5.
• Church clarifies that CRISPR acts as "genetic vandalism" (damage/deletion) rather than precision editing; in this specific case, knocking out CCR5 is the desired outcome to block the HIV receptor.
• While the double-null CCR5 status offers HIV resistance, it increases susceptibility to West Nile virus, illustrating the trade-offs inherent in preventative genetic therapies.
• Mosaicism (cells with and without edits) is a known variable in gene therapy; Church suggests the infant may not be significantly mosaic, as pre-implantation embryo sampling might not represent the final organism, and selection pressure could favor edited T-cells.
• Church compares the current scrutiny to the 1978 "test tube baby" hysteria, predicting a similar pattern where initial "n of 1" success leads to accelerated adoption and regulation rather than a permanent pause.

Ethics, Regulation, and Future Applications

• The 2017 National Academy of Sciences report established 10 prerequisites for germline editing, focusing on safety, efficacy, and ethics similar to FDA/EMA standards for therapeutic trials.
• Church predicts that ethical debates and "moratoriums" often accelerate research by attracting funding and improving containment facilities, citing the post-moratorium acceleration in DNA research.
• He advocates for strong regulation, arguing that agencies smooth out adoption rather than slow it, contrasting with the failure of incremental old therapies versus the "traumatic improvements" of new categories like monoclonal antibodies.
• Church argues the next non-incremental step is shifting from treatment to diagnosis and prevention, noting that preventative medicine currently receives only 1-5% of government agency funding despite high payback.
• For severe Mendelian diseases, Church views IVF with Preimplantation Genetic Diagnosis (PGD) as a preferred alternative to germline editing, as it avoids editing and relies on selection.
• He proposes "matchmaking" based on whole-genome sequencing to avoid couples conceiving children with incompatible genetic risks (e.g., Tay-Sachs), citing the Doria Shurim community as a successful historical precedent.

Genomic Sequencing Barriers and Security

• Despite costs dropping below $1,000, widespread whole-genome sequencing adoption is stalled due to three barriers: cost (should approach $0), privacy/security, and a misunderstood value proposition.
• Church compares genomic adoption to seatbelts, suggesting a public health mechanism (like an automated alert or benefit) is needed because individuals rarely perceive the 1-4% risk of actionable disease in themselves.
• He argues that "zero-dollar genome" services combined with encryption (where data is inaccessible even to the owner or insurance companies) could solve privacy concerns by legally and technically preventing surreptitious data harvesting.
• Forensic risks (e.g., DNA planting at crime scenes) are mitigated by advanced methylation analysis and immune status tracking, which can date DNA samples and counter-hack forensic claims.
• The Personal Genome Project (initiated 2005) required participants to pass a 100% comprehension quiz on risks before consenting, aiming to prevent "blanket" legalistic consent forms.
• Church's own genome revealed no Alzheimer's risk factors but identified him as a compound heterozygote for alpha-1 antitrypsin, prompting lifestyle changes regarding pollution and smoking.
• Public access to his medical records allowed a hematologist to identify his incorrect statin usage, leading to a dietary solution that lowered his levels significantly.

The Church Lab Culture and Future Tech

• The lab recruits for "niceness" and multidisciplinary capability over raw genius, avoiding competition and fostering a culture where failure is followed by rapid iteration ("feel fast").
• The lab has banned the word "impossible," focusing on radical transformative technologies (e.g., fluorescent sequencing, nanopore sequencing) that initially appear as science fiction.
• Current projects include CRISPR-ing dogs for longevity, editing pig organs for transplantation, and creating a "mirror universe" of organisms recoded to be immune to all known viruses.
• George Church and Jorge Conde reference their 2007 bet on whole-genome sequencing with their company "Gnome," noting that while cost thresholds are reached, utility remains limited by data interpretation and privacy.
• Future technological frontiers include 3D structural biology of embryos (mapping every voxel), massive multiplexing of genome edits (moving from 62 to 10,000 edits per cell), and the "GP Write" project.
• Regarding "de-extinction," Church prioritizes mammoth hybrids for environmental and diversity benefits over Neanderthal projects, which lack a clear articulation of societal utility.